summary of agm

Approximately 50 in attendance .It was nice to meet Brian53 and Nedcarro.

1) Nedcarro gave management a bit of a tongue lashing re. dilution of our holdings and the preferential treatment of outsiders.
2) EMA approval should come in April but the company is being cautious (allowing for delays)and is aiming for June 2014.
3) Everything is ready for sales to commence immediately.They also have a contingency "scramble" plan in place in case miraculously we get early approval.
4) Steve Mercer was apologetic about not keeping us better informed but he had to be very careful what he announced in case EMA was watching.
5)The world market applicable to our product is $35 to$40 billion a year and growing fast.(Our initial areas cover 15% of the market)
6) The financial woes in Europe and the resulting austerity measures are of great advantage to us as Vitrogro is much cheaper than existing treatments and health authorities are cutting expenditure.
7)FDA application lodged.(see announcements)
8)When asked about finances/cap.raising the reply was vague but they implied that they were in no hurry and were going to wait for the EMA approval first.

Hope you find the above useful.
I won't be selling mine !